These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
423 related articles for article (PubMed ID: 12464647)
41. Shutoff of BZLF1 gene expression is necessary for immortalization of primary B cells by Epstein-Barr virus. Yu X; McCarthy PJ; Wang Z; Gorlen DA; Mertz JE J Virol; 2012 Aug; 86(15):8086-96. PubMed ID: 22623769 [TBL] [Abstract][Full Text] [Related]
42. Identification of an epithelial cell differentiation responsive region within the BZLF1 promoter of the Epstein-Barr virus. Karimi L; Crawford DH; Speck S; Nicholson LJ J Gen Virol; 1995 Apr; 76 ( Pt 4)():759-65. PubMed ID: 9049321 [TBL] [Abstract][Full Text] [Related]
43. Fluorescence in situ hybridization is superior for monitoring Epstein Barr viral load in infectious mononucleosis patients. Cao P; Zhang M; Wang W; Dai Y; Sai B; Sun J; Wang L; Wang F; Li G; Xiang J BMC Infect Dis; 2017 May; 17(1):323. PubMed ID: 28468603 [TBL] [Abstract][Full Text] [Related]
44. ZEB1 regulates the latent-lytic switch in infection by Epstein-Barr virus. Yu X; Wang Z; Mertz JE PLoS Pathog; 2007 Dec; 3(12):e194. PubMed ID: 18085824 [TBL] [Abstract][Full Text] [Related]
45. Plasma cell-specific transcription factor XBP-1s binds to and transactivates the Epstein-Barr virus BZLF1 promoter. Sun CC; Thorley-Lawson DA J Virol; 2007 Dec; 81(24):13566-77. PubMed ID: 17898050 [TBL] [Abstract][Full Text] [Related]
46. Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome. Yoshioka M; Kikuta H; Ishiguro N; Endo R; Kobayashi K J Med Virol; 2003 Jul; 70(3):410-9. PubMed ID: 12767005 [TBL] [Abstract][Full Text] [Related]
47. Expression of Epstein-Barr virus lytic gene BRLF1 in nasopharyngeal carcinoma: potential use in diagnosis. Feng P; Ren EC; Liu D; Chan SH; Hu H J Gen Virol; 2000 Oct; 81(Pt 10):2417-2423. PubMed ID: 10993929 [TBL] [Abstract][Full Text] [Related]
48. High frequency of Epstein Barr virus latent membrane protein-1 30 bp deletion in a series of pediatric malignancies in Argentina. Chabay P; De Matteo E; Merediz A; Preciado MV Arch Virol; 2004 Aug; 149(8):1515-26. PubMed ID: 15290377 [TBL] [Abstract][Full Text] [Related]
49. Transforming growth factor beta 1 stimulates expression of the Epstein-Barr virus BZLF1 immediate-early gene product ZEBRA by an indirect mechanism which requires the MAPK kinase pathway. Fahmi H; Cochet C; Hmama Z; Opolon P; Joab I J Virol; 2000 Jul; 74(13):5810-8. PubMed ID: 10846060 [TBL] [Abstract][Full Text] [Related]
51. Identification of a novel element involved in regulation of the lytic switch BZLF1 gene promoter of Epstein-Barr virus. Kraus RJ; Mirocha SJ; Stephany HM; Puchalski JR; Mertz JE J Virol; 2001 Jan; 75(2):867-77. PubMed ID: 11134300 [TBL] [Abstract][Full Text] [Related]
52. Epstein-Barr virus (EBV) EB1/Zta protein provided in trans and competent for the activation of productive cycle genes does not activate the BZLF1 gene in the EBV genome. Le Roux F; Sergeant A; Corbo L J Gen Virol; 1996 Mar; 77 ( Pt 3)():501-9. PubMed ID: 8601788 [TBL] [Abstract][Full Text] [Related]
53. A survey of Epstein-Barr virus gene expression in sporadic non-Hodgkin's lymphomas. Detection of Epstein-Barr virus in a subset of peripheral T-cell lymphomas. Hamilton-Dutoit SJ; Pallesen G Am J Pathol; 1992 Jun; 140(6):1315-25. PubMed ID: 1318639 [TBL] [Abstract][Full Text] [Related]
54. A Mechanism-Based Targeted Screen To Identify Epstein-Barr Virus-Directed Antiviral Agents. Li X; Akinyemi IA; You JK; Rezaei MA; Li C; McIntosh MT; Del Poeta M; Bhaduri-McIntosh S J Virol; 2020 Oct; 94(21):. PubMed ID: 32796077 [TBL] [Abstract][Full Text] [Related]
55. Sequence variation of Epstein-Barr virus (EBV) BCRF1 in lymphomas in non-endemic areas of nasopharyngeal carcinoma. Han L; Sun L; Zhao Z; Chao Y; Sun Z; Li H; Luo B Arch Virol; 2015 Feb; 160(2):441-5. PubMed ID: 25373543 [TBL] [Abstract][Full Text] [Related]
56. Epstein-Barr virus (EBV) in Malaysian upper-aerodigestive-tract lymphoma: incidence and sub-type. Peh SC; Sandvej K; Pallesen G Int J Cancer; 1995 May; 61(3):327-32. PubMed ID: 7729943 [TBL] [Abstract][Full Text] [Related]
57. Epstein-Barr virus infection and human malignancies. Niedobitek G; Meru N; Delecluse HJ Int J Exp Pathol; 2001 Jun; 82(3):149-70. PubMed ID: 11488990 [TBL] [Abstract][Full Text] [Related]
58. Glucocorticoids activate Epstein Barr virus lytic replication through the upregulation of immediate early BZLF1 gene expression. Yang EV; Webster Marketon JI; Chen M; Lo KW; Kim SJ; Glaser R Brain Behav Immun; 2010 Oct; 24(7):1089-96. PubMed ID: 20466055 [TBL] [Abstract][Full Text] [Related]
59. Relationship between PPP1R15A gene polymorphism (rs611251) and Epstein-Barr virus-associated tumors. Song Y; Liu S; Zhao Z; Zhang Y; Yang Y; Luo B Acta Virol; 2017; 61(4):445-452. PubMed ID: 29186961 [TBL] [Abstract][Full Text] [Related]
60. Epstein-Barr virus BZLF1 gene is activated by transforming growth factor-beta through cooperativity of Smads and c-Jun/c-Fos proteins. Liang CL; Chen JL; Hsu YP; Ou JT; Chang YS J Biol Chem; 2002 Jun; 277(26):23345-57. PubMed ID: 11971895 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]